Skip to main content
. 2023 Oct 29;13:18554. doi: 10.1038/s41598-023-45721-z

Figure 2.

Figure 2

Synergistic proapoptotic effects of INCB057643 combined with selinexor in HGBCL-DH cells with TP53 mutations. (A,B) INCB057643 synergized with selinexor to promote apoptosis in VAL (A) and TMD8 (B) cells. The left panel shows the specific apoptosis rates, and the right panel shows the CI values. (C) Analysis of the therapeutic interaction of selinexor and INCB057643 in inducing apoptosis in Toledo cells. The top and bottom panels show the specific apoptosis rates and CI values, respectively. (D) Representative flow plots of VAL, TMD8 and Toledo cells treated as described in (AC).